Dataciencia

Colección SciELO Chile

Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America

Indexado

WoS	WOS:000278650400003
Scopus	SCOPUS_ID:77953479908

DOI

10.1016/J.IJID.2009.08.018

Año

2010

Tipo

revisión

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Abstract

Conclusions: A variety of epidemic MRSA clones are circulating in Latin America, some of which harbor genes that encode multidrug resistance or enhanced pathogenicity. Continued collection and reporting of epidemiological data is crucial for effective prevention and treatment. (C) 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Revista

Revista	ISSN
International Journal Of Infectious Diseases	1201-9712

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Infectious Diseases

Scopus
Infectious Diseases
Microbiology (Medical)

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Rodriguez-Noriega, E.	Hombre	Univ Guadalajara - México Hospital Civil de Guadalajara - México Universidad de Guadalajara - México
2	Seas, Carlos	Hombre	UNIV PERUANA CAYETANO HEREDIA - Perú Universidad Peruana Cayetano Heredia - Perú
3	Gkiokas, George	Hombre	Ctr Med Caracas - Venezuela Centro Medico Docente La Trinidad - Venezuela
4	Mejia, Carlos	Hombre	Hosp Roosevelt - Guatemala Roosevelt Hospital Guatemala - Guatemala
5	ÁLVAREZ, CARLOS	Hombre	Hosp San Ignacio - Colombia Pontificia Univ Javeriana - Colombia Pontificia Universidad Javeriana - Colombia
6	BAVESTRELLO-FERNANDEZ, LUIS	Hombre	Clínica Reñaca - Chile Clin Renaca - Chile
7	Zurita, Jeannete	Mujer	Hosp Vozandes - Ecuador Hospital Vozandes - Ecuador
8	Labarca, Jaime	Hombre	Pontificia Universidad Católica de Chile - Chile
9	Luna, Carlos	Hombre	UNIV BUENOS AIRES - Argentina Universidad de Buenos Aires - Argentina
10	COSTA-SALLES, MAURO JOSE	Hombre	Hosp Irmandade da Santa Casa de Misericordia Sao - Brasil Chandru - Brasil
11	Gotuzzo, E.	Hombre	UNIV PERUANA CAYETANO HEREDIA - Perú Universidad Peruana Cayetano Heredia - Perú

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Origen de Citas Identificadas

Muestra la distribución de países cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 16.09 %
Citas No-identificadas: 83.91 %

Muestra la distribución de instituciones nacionales o extranjeras cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 16.09 %
Citas No-identificadas: 83.91 %

Financiamiento

Fuente
Novartis
Pfizer Inc., New York, NY, USA
Abbott Laboratories
Pfizer
Johnson and Johnson
Sanofi Pasteur
Merck
Johnson Johnson
Merck Sharp and Dohme
Wyeth
Cerexa
Schering-Plough
Dohme
Avexa
Therevance
Sharp
Tibotec for HIV research
Choice Pharma

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
E. Rodriguez-Noriega: Advisory Board member for Pfizer; consultant for Pfizer, Wyeth, Johnson & Johnson, and Novartis; received research grants from Pfizer, Wyeth, Johnson & Johnson, Schering-Plough, and Cerexa. C. Seas: Advisory Board member and consultant for Pfizer; received research funding from Therevance, Cerexa, Schering-Plough and Avexa. M. Guzman-Blanco: Advisory Board member for Pfizer, Merck, and BD; consultant for Pfizer, Wyeth, Janssen; received research funding from Wyeth and Merck. C. Mejia: Advisory Board member for Pfizer and Abbott; consultant for Pfizer; received funding from Tibotec for HIV research; from Avexa for studies in HIV treatment; from Merck for participation in the SMART study. C. Alvarez: Advisory Board member for Pfizer; consultant for Pfizer, Janssen-Cilag, Glaxo Smith Kline, Baxter, Merck Sharp and Dohme and Bristol Myers Squibb. L. Bavestrello: Advisory Board member and consultant for Pfizer. J. Zurita: Advisory Board member and consultant for Pfizer; received research grant from Wyeth. J. Labarca: Advisory Board member for Pfizer; consultant for Pfizer, Merck Sharp and Dohme, and Wyeth; investigator for linezolid studies funded by Pfizer. C. M. Luna: Advisory Board member for Pfizer, Bayer, and Wyeth; consultant for Pfizer; speaker for Astra-Zeneca. M. J. C. Salles: Advisory Board member for Pfizer and Wyeth; consultant or speaker for Pfizer, Wyeth, Merck and United Medicals. E. Gotuzzo: Advisory Board member and consultant for Pfizer; received research grants from Merck, Sharp and Dohme; consultant for Sanofi Pasteur.
The support provided by Choice Pharma (Hitchin, UK), funded by Pfizer Inc., consisted solely of manuscript formatting and writing assistance and no contribution was made to editorial content.

Agradecimiento

E. Rodriguez-Noriega: Advisory Board member for Pfizer; consultant for Pfizer, Wyeth, Johnson & Johnson, and Novartis; received research grants from Pfizer, Wyeth, Johnson & Johnson, Schering-Plough, and Cerexa. C. Seas: Advisory Board member and consultant for Pfizer; received research funding from Therevance, Cerexa, Schering-Plough and Avexa. M. Guzman-Blanco: Advisory Board member for Pfizer, Merck, and BD; consultant for Pfizer, Wyeth, Janssen; received research funding from Wyeth and Merck. C. Mejia: Advisory Board member for Pfizer and Abbott; consultant for Pfizer; received funding from Tibotec for HIV research; from Avexa for studies in HIV treatment; from Merck for participation in the SMART study. C. Alvarez: Advisory Board member for Pfizer; consultant for Pfizer, Janssen-Cilag, Glaxo Smith Kline, Baxter, Merck Sharp and Dohme and Bristol Myers Squibb. L. Bavestrello: Advisory Board member and consultant for Pfizer. J. Zurita: Advisory Board member and consultant for Pfizer; received research grant from Wyeth. J. Labarca: Advisory Board member for Pfizer; consultant for Pfizer, Merck Sharp and Dohme, and Wyeth; investigator for linezolid studies funded by Pfizer. C. M. Luna: Advisory Board member for Pfizer, Bayer, and Wyeth; consultant for Pfizer; speaker for Astra-Zeneca. M. J. C. Salles: Advisory Board member for Pfizer and Wyeth; consultant or speaker for Pfizer, Wyeth, Merck and United Medicals. E. Gotuzzo: Advisory Board member and consultant for Pfizer; received research grants from Merck, Sharp and Dohme; consultant for Sanofi Pasteur.

The support provided by Choice Pharma (Hitchin, UK), funded by Pfizer Inc., consisted solely of manuscript formatting and writing assistance and no contribution was made to editorial content.